[Corrigendum] Aurora kinase inhibitors:�Potential molecular-targeted drugs for gynecologic malignant tumors (Review)
نویسندگان
چکیده
منابع مشابه
Oncofertility in Gynecologic Malignant Tumors
Long-term survival is the priority in treatment of patients with malignant tumors. In the field of gynecology, fertility preservation has also recently become an important objective due to improved treatment outcomes and different needs of patients. Methods for fertility preservation include cervical conization, ovarian protection against radiation or chemotherapy for ovarian cancer since the o...
متن کاملCurrent status of molecular-targeted drugs for endometrial cancer (Review)
Endometrial cancer is a common gynecological malignant tumor in Western countries and its incidence has also been on the increase in Asia. Genetic abnormalities related to onset and progression of malignancy in the endometrial membrane and signaling system have been identified and the developmental mechanism of endometrial cancer is becoming elucidated. The identification of the molecules relat...
متن کاملCorrigendum: Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells
[This corrects the article on p. 58 in vol. 3, PMID: 23519775.].
متن کاملA genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors.
Aurora kinase A (Aurora-A) belongs to a highly conserved family of mitotis-regulating serine/threonine kinases implicated in epithelial cancers. Initially we examined Aurora-A expression levels at different stages of human skin cancer. Nuclear Aurora-A was detected in benign lesions and became more diffused but broadly expressed in well and poorly differentiated squamous cell carcinomas (SCC), ...
متن کاملAdvanced hepatocellular carcinoma. Review of targeted molecular drugs.
Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world in terms of incidence, accounting for approximately 630 thousand new cases per year; in addition, HCC is the third most common cause of cancer death. Worldwide, the greatest risk factors for HCC are the infections caused by hepatitis B and C viruses, which increase the risk of developing the disease by about 20 times. T...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biomedical Reports
سال: 2019
ISSN: 2049-9434,2049-9442
DOI: 10.3892/br.2019.1249